pmid,title,journal,year,drug,disease
39934499,MiRNA-21 promotes the migration and proliferation of prostate cancer cells via activating the JAK/STAT pathway.,Discover oncology,2025,Ruxolitinib,Prostate Cancer
38817459,Vitiligo and Prostate Cancer Correlation.,Cureus,2024,Ruxolitinib,Prostate Cancer
37462480,"[Up-regulated expression of miR-576 inhibits ALK4 expression, regulates JAK/STAT signaling pathway and promotes proliferation and migration of prostatic cancer cells].",Zhonghua nan ke xue = National journal of andrology,2022,Ruxolitinib,Prostate Cancer
34322995,Inhibition of Janus Kinase 1 synergizes docetaxel sensitivity in prostate cancer cells.,Journal of cellular and molecular medicine,2021,Ruxolitinib,Prostate Cancer
33230423,Important updates from the AACR virtual meeting: COVID-19 and cancer.,Future science OA,2020,Ruxolitinib,Prostate Cancer
32196489,IL-6 produced by prostate epithelial cells stimulated with Trichomonas vaginalis promotes proliferation of prostate cancer cells by inducing M2 polarization of THP-1-derived macrophages.,PLoS neglected tropical diseases,2020,Ruxolitinib,Prostate Cancer
29030706,Rare ADAR and RNASEH2B variants and a type I interferon signature in glioma and prostate carcinoma risk and tumorigenesis.,Acta neuropathologica,2017,Ruxolitinib,Prostate Cancer
20506062,"Ruxolitinib, a selective JAK1 and JAK2 inhibitor for the treatment of myeloproliferative neoplasms and psoriasis.",IDrugs : the investigational drugs journal,2010,Ruxolitinib,Prostate Cancer
